Schedule 13D ownership disclosure
EDESA BIOTECH INC
Common Shares, no par value per share · CUSIP: 27966L306
Event date: 2025-02-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Pardeep Nijhawan Medicine Professional Corporation
Shares: 1,119,981.00 · Class: 14.5%
- The Digestive Health Clinic Inc.
Shares: 32,013.00 · Class: 0.5%
- 1968160 Ontario Inc.
Shares: 53,104.00 · Class: 0.8%
- The New Nijhawan Family Trust 2015
Shares: 48,914.00 · Class: 0.7%
- Pardeep NijhawanReported CIK 0001777962
Shares: 1,596,581.00 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001171843-25-000871
- Form type
- SCHEDULE 13D/A
- Filer
- Edesa Biotech, Inc.
- CIK
- CIK 1540159
- Filed
- Feb 14, 2025
- Reporting period
- Feb 12, 2025
- Description
- Schedule 13D beneficial ownership